S'abonner

Performance of the ACEF and ACEF II risk scores in predicting mortality after off-pump coronary artery bypass grafting - 28/04/22

Doi : 10.1016/j.jclinane.2022.110693 
Jae-Woo Ju a, Karam Nam a, , Hyunsook Hong b, Hyeon Cheun a, Jinyoung Bae a, Seohee Lee a, Youn Joung Cho a, Yunseok Jeon a
a Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea 
b Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Republic of Korea 

Corresponding author at: Department of Anesthesiology and Pain Medicine, Seoul National University Hospital, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 03080, Republic of Korea.Department of Anesthesiology and Pain MedicineSeoul National University HospitalSeoul National University College of Medicine101 Daehak-ro, Jongno-gu, Seoul 03080Republic of Korea

Abstract

Study objective

The age, creatinine, and ejection fraction (ACEF) I and II scores are known to predict operative mortality after cardiac surgery. However, data from few cases of off-pump coronary artery bypass grafting (OPCAB) were considered during the development of these scores. This study aimed to validate and update the ACEF I and II scores for the prediction of in-hospital mortality after OPCAB.

Design

Single-center retrospective observational study.

Setting

Tertiary university hospital.

Patients

All adult patients (≥18 years) who underwent isolated OPCAB between 2011 and 2020 were included in our analysis.

Measurements

Predicted in-hospital mortality after OPCAB was calculated using ACEF and ACEF II scores. Performance of ACEF I and II scores in predicting in-hospital mortality after OPCAB was evaluated using receiver operating characteristics curves and calibration plots. Scores were recalibrated and modified using the closed testing procedure and multivariable fractional polynomial analysis.

Main results

In total, 1450 patients were analyzed. The ACEF I and II scores discriminated in-hospital mortality with the c-statistics of 0.86 and 0.83, respectively. The calibration plots revealed that both scores overestimated the risk of in-hospital mortality. The ACEF I score was recalibrated by re-estimating only the model intercept. The ACEF II score was modified by substituting hematocrit with left main coronary artery disease. The c-statistic of the updated ACEF II score increased to 0.86. Both the updated ACEF I and II scores were well-calibrated.

Conclusions

The ACEF I and II scores discriminated in-hospital mortality after OPCAB with excellent accuracy, although calibration properties were suboptimal. The updated scores showed even better discrimination and calibration. Thus, the ACEF I and ACEF II scores can be relatively straightforward and useful tools for prognostication of patients undergoing OPCAB.

Le texte complet de cet article est disponible en PDF.

Highlights

ACEF I and II scores accurately discriminated in-hospital mortality after OPCAB.
However, calibration performance of the scores was suboptimal.
Updated ACEF I and II scores showed even better discrimination and calibration.
ACEF I and II scores are useful for prognostication of patients undergoing OPCAB.

Le texte complet de cet article est disponible en PDF.

Keywords : Cardiac surgery, Coronary artery bypass grafting, External validation, Mortality, Risk scores


Plan


© 2022  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 79

Article 110693- août 2022 Retour au numéro
Article précédent Article précédent
  • Pectoserratus plane block versus erector spinae plane block for postoperative opioid consumption and acute and chronic pain after breast cancer surgery: A randomized controlled trial
  • Caner Genc, Cengiz Kaya, Sezgin Bilgin, Burhan Dost, Yasemin Burcu Ustun, Ersin Koksal
| Article suivant Article suivant
  • Optimum programmed intermittent epidural bolus interval time between 8 mL boluses of Ropivacaine 0.1% with sufentanil 0.3 μg/mL with dural puncture epidural technique for labor analgesia: A biased-coin up-and-down sequential allocation trial
  • Yujie Song, Weijia Du, Yiyi Tao, Qian Li, Fuyi Shen, Zhendong Xu, Zhiqiang Liu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.